Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
United Therapeutics Corporation (UTHR) had Cost of Goods Sold of $103.40M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$790.20M |
|
$364.30M |
|
|
Cost of Goods Sold |
$103.40M |
$686.80M |
|
$433.50M |
|
$356.70M |
|
$87.30M |
|
$444.00M |
|
$444.00M |
|
$364.30M |
|
$364.30M |
|
$364.30M |
|
$364.30M |
|
$356.70M |
|
$379.50M |
|
44.30M |
|
47.90M |
|
$8.36 |
|
$7.66 |
|
| Balance Sheet Financials | |
$3.70B |
|
$1.73B |
|
$4.18B |
|
$7.88B |
|
$560.60M |
|
-- |
|
$223.20M |
|
$783.80M |
|
$7.10B |
|
$6.98B |
|
$7.10B |
|
43.64M |
|
| Cash Flow Statement Financials | |
$1.56B |
|
$-551.30M |
|
$-1.15B |
|
$1.70B |
|
$1.56B |
|
$-140.10M |
|
$147.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.91% |
|
45.14% |
|
45.14% |
|
-- |
|
56.19% |
|
46.10% |
|
$1.04B |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.56 |
|
2.26 |
|
39.89 |
|
5.13% |
|
5.22% |
|
4.62% |
|
5.13% |
|
$162.60 |
|
$21.73 |
|
$32.59 |
|